Siemens Water Technologies introduces Nosogard infection control filters that aim to help prevent pathogens in water used in the health care industry. The seven, 14 or 30-day point-of-use sterile filters feature a design that combines a 1.0-micron pre-filter and a 0.2-micron microporous membrane to remove waterborne pathogenic organisms. The filters are individually integrity tested, performance-validated and shipped in radio-sterilized packaging with peel-able lids to maintain sterility.
Waterborne pathogens have been linked to nosocomial infections such as legionella pneumophila, stenotrophomonas maltophilia and pseudomonas aeruginosa. These pathogens can be passed to patients through drinking water and ice, hand washing, showering and medical equipment rinsed in tap water. Immuno-compromised patents, such as newborns, the elderly, burn victims and transplant patients are especially vulnerable. Nosocomial infections are estimated to be responsible for up to 10% of patient infections and even patient deaths, adding billions of dollars in excess healthcare costs.
“Siemens’ Nosogard filters are an economical way of preventing waterborne infections, and therefore helping to ensure patient safety,” said Nick Amstrong, product manager for Health Science Solutions at Siemens Water Technologies. “The filters are one of the latest offerings in a line of water treatment products from Siemens Water Technologies to improve water quality and safety for customers worldwide.”
The seven-day and 14-day Nosogard filters are validated to remove all organisms and the 30-day Nosogard filters are validated to remove legionella only for 30 days.
Source: Siemens
